Code Biotherapeutics snags $10m
Code Biotherapeutics Inc, a next-generation gene therapy company, has secured $10 million in financing.
Code Biotherapeutics Inc, a next-generation gene therapy company, has secured $10 million in financing.
Copyright PEI Media
Not for publication, email or dissemination